Author

Aziz Shaibani

Observed name: Shaibani, Aziz

Institution: Baylor College of Medicine

Observed institution: Baylor College of Medicine

OpenAlex ID: A5136361977

Management of Exacerbations and Rescue Therapy in the Phase 3 Myasthenia Gravis Inebilizumab Trial

2026 · Richard J. Nowak, Kimiaki Utsugisawa, et al. · JAMA Neurology · 1

3.61P Clinical outcome trajectories in inclusion body myositis stratified by anti-NT5c1A serostatus

2026 · Karina Bjazevic, Isela Hernandez, et al. · Neuromuscular Disorders

3.89P Comparative evaluation of respiratory assessments in inclusion body myositis from INSPIRE-IBM study

2026 · Isela Hernandez, Namita Goyal, et al. · Neuromuscular Disorders

Online Patient Ratings of a Neuromuscular Outpatient Practice: A Retrospective Study

2026 · Aziz Shaibani, Jannat Hussain, et al. · RRNMF Neuromuscular Journal

Rapid and Sustained Efficacy of Subcutaneously Administered Cemdisiran Without Complete Complement Blockade in Patients with Generalized Myasthenia Gravis (gMG): Primary Efficacy and Safety Results from the Phase Three NIMBLE Trial (PL5.002)

2026 · Tuan Vu, Ali Habib, et al. · Neurology

Phase II/III Study of Ulviprubart in Inclusion Body Myositis: Study Design, Patient Characteristics, and Topline Results (S7.007)

2026 · Namita A. Goyal, Pedro M. Machado, et al. · Neurology

Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial

2026 · J. Dawn Abbott, Jocelyne R. Benatar, et al. · Circulation

Phase 2/3 study of an investigational anti-inflammatory biologic therapy in inclusion body myositis

2026 · Goyal, Namita, Machado, Pedro, et al. · Ghent University Academic Bibliography (Ghent University)

Works count: 8

Citation count: 1

H-index: 1

I10-index: